Literature DB >> 26621848

Analysis of Monoclonal Antibody Sequence and Post-translational Modifications by Time-controlled Proteolysis and Tandem Mass Spectrometry.

Lichao Zhang1, A Michelle English1, Dina L Bai1, Scott A Ugrin1, Jeffrey Shabanowitz1, Mark M Ross1, Donald F Hunt2, Wei-Han Wang3.   

Abstract

Methodology for sequence analysis of ∼150 kDa monoclonal antibodies (mAb), including location of post-translational modifications and disulfide bonds, is described. Limited digestion of fully denatured (reduced and alkylated) antibody was accomplished in seconds by flowing a sample in 8murea at a controlled flow rate through a micro column reactor containing immobilized aspergillopepsin I. The resulting product mixture containing 3-9 kDa peptides was then fractionated by capillary column liquid chromatography and analyzed on-line by both electron-transfer dissociation and collisionally activated dissociation mass spectrometry (MS). This approach enabled identification of peptides that cover the complete sequence of a murine mAb. With customized tandem MS and ProSightPC Biomarker search, we verified 95% amino acid residues of this mAb and identified numerous post-translational modifications (oxidized methionine, pyroglutamylation, deamidation of Asn, and several forms ofN-linked glycosylation). For disulfide bond location, native mAb is subjected to the same procedure but with longer digestion times controlled by sample flow rate through the micro column reactor. Release of disulfide containing peptides from accessible regions of the folded antibody occurs with short digestion times. Release of those in the interior of the molecule requires longer digestion times. The identity of two peptides connected by a disulfide bond is determined using a combination of electron-transfer dissociation and ion-ion proton transfer chemistry to read the two N-terminal and two C-terminal sequences of the connected peptides.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26621848      PMCID: PMC4824869          DOI: 10.1074/mcp.O115.056721

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  24 in total

1.  Characterization of a recombinant monoclonal antibody by mass spectrometry combined with liquid chromatography.

Authors:  L E Matamoros Fernández; D E Kalume; L Calvo; M Fernández Mallo; A Vallin; P Roepstorff
Journal:  J Chromatogr B Biomed Sci Appl       Date:  2001-03-10

2.  Open mass spectrometry search algorithm.

Authors:  Lewis Y Geer; Sanford P Markey; Jeffrey A Kowalak; Lukas Wagner; Ming Xu; Dawn M Maynard; Xiaoyu Yang; Wenyao Shi; Stephen H Bryant
Journal:  J Proteome Res       Date:  2004 Sep-Oct       Impact factor: 4.466

Review 3.  Mass spectrometry for structural characterization of therapeutic antibodies.

Authors:  Zhongqi Zhang; Hai Pan; Xiaoyu Chen
Journal:  Mass Spectrom Rev       Date:  2009 Jan-Feb       Impact factor: 10.946

4.  Methods for analyzing peptides and proteins on a chromatographic timescale by electron-transfer dissociation mass spectrometry.

Authors:  Namrata D Udeshi; Philip D Compton; Jeffrey Shabanowitz; Donald F Hunt; Kristie L Rose
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

5.  Proteome digestion specificity analysis for rational design of extended bottom-up and middle-down proteomics experiments.

Authors:  Ünige A Laskay; Anna A Lobas; Kristina Srzentić; Mikhail V Gorshkov; Yury O Tsybin
Journal:  J Proteome Res       Date:  2013-10-30       Impact factor: 4.466

6.  Protein derivatization and sequential ion/ion reactions to enhance sequence coverage produced by electron transfer dissociation mass spectrometry.

Authors:  Lissa C Anderson; A Michelle English; Weihan Wang; Dina L Bai; Jeffrey Shabanowitz; Donald F Hunt
Journal:  Int J Mass Spectrom       Date:  2015-02-01       Impact factor: 1.986

7.  Data-dependent middle-down nano-liquid chromatography-electron capture dissociation-tandem mass spectrometry: an application for the analysis of unfractionated histones.

Authors:  Anastasia Kalli; Michael J Sweredoski; Sonja Hess
Journal:  Anal Chem       Date:  2013-03-12       Impact factor: 6.986

Review 8.  Mass spectrometric analysis of asparagine deamidation and aspartate isomerization in polypeptides.

Authors:  Hongqian Yang; Roman A Zubarev
Journal:  Electrophoresis       Date:  2010-06       Impact factor: 3.535

9.  Extended Range Proteomic Analysis (ERPA): a new and sensitive LC-MS platform for high sequence coverage of complex proteins with extensive post-translational modifications-comprehensive analysis of beta-casein and epidermal growth factor receptor (EGFR).

Authors:  Shiaw-Lin Wu; Jeongkwon Kim; William S Hancock; Barry Karger
Journal:  J Proteome Res       Date:  2005 Jul-Aug       Impact factor: 4.466

10.  High-throughput middle-down analysis using an orbitrap.

Authors:  Joe Cannon; Karen Lohnes; Colin Wynne; Yan Wang; Nathan Edwards; Catherine Fenselau
Journal:  J Proteome Res       Date:  2010-08-06       Impact factor: 4.466

View more
  12 in total

1.  Sequencing a Bispecific Antibody by Controlling Chain Concentration Effects When Using an Immobilized Nonspecific Protease.

Authors:  Robert A D'Ippolito; Maria C Panepinto; Keira E Mahoney; Dina L Bai; Jeffrey Shabanowitz; Donald F Hunt
Journal:  Anal Chem       Date:  2020-07-13       Impact factor: 6.986

2.  The Value of Activated Ion Electron Transfer Dissociation for High-Throughput Top-Down Characterization of Intact Proteins.

Authors:  Nicholas M Riley; Jacek W Sikora; Henrique S Seckler; Joseph B Greer; Ryan T Fellers; Richard D LeDuc; Michael S Westphall; Paul M Thomas; Neil L Kelleher; Joshua J Coon
Journal:  Anal Chem       Date:  2018-07-05       Impact factor: 6.986

3.  Recent Developments in Gas-Phase Ion/Ion Reactions for Analytical Mass Spectrometry.

Authors:  David J Foreman; Scott A McLuckey
Journal:  Anal Chem       Date:  2019-11-26       Impact factor: 6.986

4.  Analysis of Monoclonal Antibodies in Human Serum as a Model for Clinical Monoclonal Gammopathy by Use of 21 Tesla FT-ICR Top-Down and Middle-Down MS/MS.

Authors:  Lidong He; Lissa C Anderson; David R Barnidge; David L Murray; Christopher L Hendrickson; Alan G Marshall
Journal:  J Am Soc Mass Spectrom       Date:  2017-02-28       Impact factor: 3.109

5.  Front-End Electron Transfer Dissociation Coupled to a 21 Tesla FT-ICR Mass Spectrometer for Intact Protein Sequence Analysis.

Authors:  Chad R Weisbrod; Nathan K Kaiser; John E P Syka; Lee Early; Christopher Mullen; Jean-Jacques Dunyach; A Michelle English; Lissa C Anderson; Greg T Blakney; Jeffrey Shabanowitz; Christopher L Hendrickson; Alan G Marshall; Donald F Hunt
Journal:  J Am Soc Mass Spectrom       Date:  2017-07-18       Impact factor: 3.109

6.  Unambiguous Sequence Characterization of a Monoclonal Antibody in a Single Analysis Using a Nonspecific Immobilized Enzyme Reactor.

Authors:  Joshua D Hinkle; Robert A D'Ippolito; Maria C Panepinto; Wei-Han Wang; Dina L Bai; Jeffrey Shabanowitz; Donald F Hunt
Journal:  Anal Chem       Date:  2019-10-16       Impact factor: 6.986

7.  Sequencing Larger Intact Proteins (30-70 kDa) with Activated Ion Electron Transfer Dissociation.

Authors:  Nicholas M Riley; Michael S Westphall; Joshua J Coon
Journal:  J Am Soc Mass Spectrom       Date:  2017-10-12       Impact factor: 3.109

8.  Ion Activation Methods for Peptides and Proteins.

Authors:  Luis A Macias; Inês C Santos; Jennifer S Brodbelt
Journal:  Anal Chem       Date:  2019-11-12       Impact factor: 6.986

9.  Top-Down Characterization of an Intact Monoclonal Antibody Using Activated Ion Electron Transfer Dissociation.

Authors:  Jean M Lodge; Kevin L Schauer; Dain R Brademan; Nicholas M Riley; Evgenia Shishkova; Michael S Westphall; Joshua J Coon
Journal:  Anal Chem       Date:  2020-07-16       Impact factor: 6.986

Review 10.  The Role of Electron Transfer Dissociation in Modern Proteomics.

Authors:  Nicholas M Riley; Joshua J Coon
Journal:  Anal Chem       Date:  2017-12-12       Impact factor: 6.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.